跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML - PPB Drug Approval Details
Approvals
/
PPB
/
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML
Approved
STANDARD
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML
BAYER HEALTHCARE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
df4478e8eb76fe68
Company
BAYER HEALTHCARE LIMITED
Type
Standard
Approval Details
Approval Id
df4478e8eb76fe68
Product Name
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML
Drug Hk Name
XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML
Registration Code
HK-67498
Company Name
BAYER HEALTHCARE LIMITED
Company Detail Path
/organization/bayer-healthcare-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2022-07-13
Company Address
14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
df4478e8eb76fe68
Type
Standard
Back to PPB Approvals